Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +36.36%
#2 Versatize Coin Versatize Coin +32.50%
#3 Purr Purr +30.40%
#4 Siren Siren +30.34%
#5 ApeX ApeX +15.66%
#6 OriginTrail OriginTrail +15.24%
#7 Pendle Pendle +14.37%
#8 UnifAI Network UnifAI Network +13.81%
#9 龙虾 (Lobster) 龙虾 (Lobster) +13.15%
#10 Morpho Morpho +13.10%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Cyteir Therapeutics, Inc. Cyteir Therapeutics, Inc.

Cyteir Therapeutics, Inc.

CYT
Clasificación en acciones #21570
Cyteir Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated... Cyteir Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to innovating and bringing to market cutting-edge precision oncology medicines. Its flagship compound, CYT-0851, is an novel, orally administered small molecule drug candidate, designed for once-daily dosing. This therapy is currently undergoing Phase I/II clinical evaluations, both as a standalone treatment and in combination with other drugs, targeting a broad range of solid tumors and hematologic malignancies. Furthermore, the company is advancing CYT-1853, another promising candidate in preclinical development for similar oncological indications. Cyteir Therapeutics was established in 2012 and is headquartered in Lexington, Massachusetts.
Precio por acción
$3.01
Última sincronización: 2024-04-12
Capitalización bursátil
$104.64M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Cyteir Therapeutics, Inc. (CYT)

Categoría

Healthcare
Historial del precio de la acción de Cyteir Therapeutics, Inc. (CYT)
Precio más alto de cierre: $3.01 el 2024-04-01

Precio más bajo de cierre: $18.73 el 2021-06-01
Historial del precio de la acción de Cyteir Therapeutics, Inc. desde 2021 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2024 -2.00%
2023 125.69%
2022 -88.47%
2021 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.71 38.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 58.06%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.75 437.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -15.60%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 8.98%
CH